InvestorsHub Logo

biotech jim

07/22/13 10:10 AM

#164315 RE: DewDiligence #164313

Dew, I think you meant to say CRP instead of CGRP. The latter is the peptide strongly implicated in dural vasodilation related to migraine attacks. I will venture to say that Servier does not want them to publicly state the precise value?

All the best,

BJ

iwfal

07/22/13 2:32 PM

#164322 RE: DewDiligence #164313

Curiously, XOMA still hasn’t said what the cutoff value is between high CGRP and low CGRP for the two EOA trials.



I believe that when they first announced the new trial they said that the cutoff on the original trial was 2. But I don't believe it was in my notes - so it is subject to memory errors.